heparan sulfate proteoglycans | Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

4,367 results for “heparan sulfate proteoglycans”

Trials

View all 3748 →

Colorectal Omics and OfCS Proteoglycans

1,000 participants · First posted Mar 1, 2024

Colorectal Omics and ofCS Proteoglycans (COCO) in Screening and a Diagnostic Pathway

2,000 participants · First posted Nov 20, 2025

Not yet recruiting

Randomized, Placebo-crontrolled Clinical Trial Evaluating the Efficacy and Safety of Heparan Sulfate 120 mg Prolonged-Release Tablets Compared With Placebo in Patients With Chronic Venous Disease

174 participants · First posted Jul 6, 2026

Drugs

View all 492 →

heparan sulfate

EP-80061

Investigational

Heparan-N-sulfatase (human, recombinant)

Organizations

View all 11 →

Jilin Province Xidian Pharmaceutical SciTech Development Co.,Ltd

Yantai Dongcheng Pharmaceutical Group Co.,Ltd.

华仁药业股份有限公司

News

View all 116 →

Kalaris Therapeutics to Present First-in-Human Data for Novel Dual-Targeting AMD Therapy TH103

NanoViricides' NV-387 Advances to Phase II Trials for Multiple Viral Infections

NanoViricides Advances NV-387 as Potential Treatment for Measles Amid Declining Vaccination Rates

Page 1 of 437